Immunome (IMNM) Asset Utilization Ratio (2020 - 2026)
Immunome's Asset Utilization Ratio came in at 0.01 for Q1 2026, down 83.6% from 0.04 a year earlier and down 56.4% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
For FY2025, Immunome's Asset Utilization Ratio was 0.02, down 67.7% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.05 in FY2024 (-71.4%) and 0.16 in FY2023.
- The Q1 2026 figure represents the lowest quarterly Asset Utilization Ratio in data going back to Q4 2023.
- Year-over-year, Asset Utilization Ratio has declined for three consecutive quarters, with an average decline of 40.5% over the last six quarters.
- Business Quant data shows IMNM's Asset Utilization Ratio at 0.01 (Q4 2025), 0.03 (Q3 2025) and 0.04 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Immunome | 2.04 Bn | 11.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.15 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
API Access
Immunome Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();